Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Total Non-Current Liabilities (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $17.2 million as the latest value for Q4 2019.

  • Quarterly Total Non-Current Liabilities changed N/A to $17.2 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $17.2 million through Dec 2019, changed N/A year-over-year, with the annual reading at $17.2 million for FY2019, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q4 2019 was $17.2 million at Forte Biosciences, down from $50.9 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $50.9 million in Q3 2019, with the low at $17.2 million in Q4 2019.
  • Average Total Non-Current Liabilities over 3 years is $33.0 million, with a median of $32.0 million recorded in 2016.